Jyh-Cheng Chen Selected Research

Jyh-Cheng Chen Research Topics

Disease

18	Neoplasms (Cancer) 04/2022 - 05/2005
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022 - 10/2015
11	Lung Neoplasms (Lung Cancer) 04/2022 - 12/2015
8	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2022 - 11/2016
6	Adenocarcinoma of Lung 04/2022 - 11/2016
4	Brain Neoplasms (Brain Tumor) 04/2014 - 02/2004
4	Glioma (Gliomas) 04/2014 - 02/2004
3	Complementation Group C Xeroderma Pigmentosum 01/2021 - 01/2018
3	Pain (Aches) 10/2008 - 01/2006
2	Adenocarcinoma 01/2021 - 01/2017
2	Sarcoma (Soft Tissue Sarcoma) 02/2016 - 07/2006
2	Parkinson Disease (Parkinson's Disease) 10/2011 - 01/2011
1	Squamous Cell Carcinoma of Head and Neck 11/2021

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 04/2022 - 12/2013
4	Pharmaceutical PreparationsIBA 04/2022 - 12/2015
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 01/2017
4	Thymidylate SynthaseIBA 01/2020 - 11/2016
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 04/2016
3	tanespimycin (17AAG)IBA 01/2021 - 01/2018
3	p38 Mitogen-Activated Protein KinasesIBA 01/2021 - 06/2016
3	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 06/2016
3	salinomycinIBA 01/2019 - 12/2016
3	astaxanthine (astaxanthin)IBA 11/2018 - 04/2016
2	Nitroglycerin (Dynamite)FDA LinkGeneric 04/2022 - 01/2020
2	Folic Acid AntagonistsIBA 04/2022 - 11/2016
2	Pemetrexed (MTA)FDA Link 04/2022 - 11/2016
2	Therapeutic UsesIBA 01/2021 - 01/2020
2	ErbB Receptors (EGF Receptor)IBA 05/2019 - 01/2017
2	Tyrosine Kinase InhibitorsIBA 05/2019 - 01/2017
2	Topoisomerase II InhibitorsIBA 01/2018 - 12/2015
2	Etoposide (VP 16)FDA LinkGeneric 01/2018 - 12/2015
2	Complement System Proteins (Complement)IBA 06/2016 - 12/2015
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 04/2016 - 10/2015
2	Tetracycline (Achromycin)FDA LinkGeneric 10/2015 - 07/2006
2	Ketamine FDA LinkGeneric 10/2008 - 11/2005
2	Formaldehyde (Formol)FDA Link 06/2008 - 01/2006
2	BoronIBA 11/2005 - 02/2004
1	RadiopharmaceuticalsIBA 11/2021
1	GoldIBA 11/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	Fluorouracil (Carac)FDA LinkGeneric 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	EnzymesIBA 01/2020
1	ThymidineIBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2020
1	Capsaicin (Zostrix)FDA Link 05/2019
1	Thymidine PhosphorylaseIBA 01/2019
1	IonophoresIBA 01/2019
1	A-Form DNA (A-DNA)IBA 01/2018
1	Potassium IonophoresIBA 12/2016
1	CurcuminIBA 06/2016
1	Phosphotransferases (Kinase)IBA 04/2016
1	ProdrugsIBA 02/2016
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 02/2016
1	Annexin A5IBA 02/2016
1	X-ray Repair Cross Complementing Protein 1IBA 12/2015
1	ResveratrolIBA 12/2015
1	Minocycline (Cyclops)FDA LinkGeneric 10/2015
1	NeurotoxinsIBA 10/2011
1	ChloraloseIBA 01/2006
1	Boron CompoundsIBA 11/2005
1	Isoflurane FDA LinkGeneric 11/2005
1	Mannitol (Osmitrol)FDA LinkGeneric 11/2005
1	Tyrosine (L-Tyrosine)FDA Link 05/2005
1	Amino Acids FDA Link 05/2005
1	Phenylalanine (L-Phenylalanine)FDA Link 05/2005
1	(18F)fluoroethyltyrosineIBA 05/2005
1	FructoseIBA 05/2005
1	Glucose (Dextrose)FDA LinkGeneric 05/2005
1	4-boronophenylalanineIBA 02/2004
1	Biological ProductsIBA 02/2004

Therapy/Procedure

4	Therapeutics 01/2021 - 02/2004
3	Drug Therapy (Chemotherapy) 01/2020 - 04/2016
3	Boron Neutron Capture Therapy 04/2014 - 02/2004
2	Intravenous Injections 04/2014 - 11/2005
1	Brachytherapy 11/2021
1	Lasers (Laser) 01/2011
1	Anesthesia 11/2005